A detailed history of Caitong International Asset Management Co., LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 643 shares of UTHR stock, worth $299,895. This represents 0.19% of its overall portfolio holdings.

Number of Shares
643
Previous 3 21333.33%
Holding current value
$299,895
Previous $862,000 31170.53%
% of portfolio
0.19%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025

BUY
$274.7 - $438.75 $175,808 - $280,800
640 Added 21333.33%
643 $270 Million
Q2 2025

Jul 31, 2025

BUY
$276.47 - $328.4 $829 - $985
3 New
3 $862,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.